Interleukin-6 and the soluble interleukin-6 receptor induce stem cell factor and Flt-3L expression in vivo and in vitro

Experimental Hematology

Volumn 29, Issue 2, 2001, Pages 146-155

  Peters, M ^a   Solem, F ^a   Goldschmidt, J ^a   Schirmacher, P ^b   Rose John, S ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Flt 3L; Hematopoiesis; Interleukin 6; Soluble interleukin 6 receptor; Stem cell factor

Indexed keywords

CYTOKINE; FLT3 LIGAND; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; STEM CELL FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GOAT; HEMATOPOIETIC STEM CELL; IMMUNOHISTOCHEMISTRY; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; TARGET CELL; TRANSGENIC ANIMAL;

3T3 CELLS; ANIMALS; BLOTTING, NORTHERN; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HEMATOPOIESIS, EXTRAMEDULLARY; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSORBENT TECHNIQUES; INTERLEUKIN-6; LIVER; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; RECEPTORS, INTERLEUKIN-6; RNA, MESSENGER; SOLUBILITY; SPLEEN; STEM CELL FACTOR;

ANIMALIA; MURINAE; MUS MUSCULUS;

EID: 0035140918     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(00)00650-0     Document Type: Article

References (40)

1. Gp130 and the interleukin-6 family of cytokines
2. Interleukin-6 and soluble interleukin-6-receptor; direct stimulation of gp130 and hematopoiesis
3. STATs and gene regulation
4. Jaks and stats; biological implications
5. The therapeutic potential of interleukin-6 hyperagonists and antagonists
6. The soluble interleukin-6 receptor is generated by shedding
7. Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor
8. C-reactive protein; a physiological activator of interleukin 6 receptor shedding
9. Pore-forming toxins trigger shedding of receptors for interleukin 6 and lipopolysaccharide
10. The function of the soluble interleukin 6 (IL-6) receptor in vivo; sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6
11. Development of progressive kidney damage and myeloma kidney in interleukin-6 transgenic mice
12. Extramedullary expansion of hematopoietic progenitor cells in IL-6/sIL-6R double transgenic mice
13. Differential regulation of stem cell factor mRNA expression in human endothelial cells by bacterial pathogens; an in vitro model of inflammation
14. Downregulation of c-kit expression in human endothelial cells by inflammatory stimuli
15. Gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells
16. A designer cytokine with high activity on human hematopoietic progenitor cells
17. Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells; novel responses to Flt3-ligand and thrombopoietin
18. Ontogeny-associated changes in the cytokine responses of primitive human hematopoietic cells
19. C-kit ligand and Flt-3 ligand; stem/progenitor cell factors with overlapping yet distinct activities
20. Differential effects of phorbol esters on c-fos and c-myc and ornithine decarboxylase gene expression in mouse skin in vivo
21. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
22. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
23. Hepatocellular hyperplasia, plasmacytoma formation and extramedullary hematopoiesis in IL-6/sIL-6R double transgenic mice
24. Differential expression and processing of two cell associated forms of the kit-ligand; KL-1 and KL-2
25. Consequences of exclusive expression in vivo of kit-ligand lacking the major proteolytic cleavage site
26. Developmental changes in the differentiation capacity of haematopoietic stem cells
27. Stem cell factor and hematopoiesis
28. The FLT3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells in vitro; synergistic interactions with interleukin (IL) 11, 12, and other hematopoietic growth factors
29. FLT3/FLK2 ligand promotes the growth of murine stem cells and the expansion of colony-forming cells and spleen colony-forming units
30. Thrombopoietin, the ligand for the Mpl receptor, synergizes with steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice
31. Recombinant rat stem cell factor stimulates the amplification and differentiation of fractionated mouse stem cell populations
32. Stem cell factor increases colony-forming unit-spleen number in vitro in synergy with interleukin-6, and in vivo in Sl/Sld mice as a single factor
33. Bone marrow transplantation with interleukin-1 plus kit-ligand ex vivo expanded bone marrow accelerates hematopoietic reconstitution in mice without the loss of stem cell lineage and proliferative potential
34. Analysis of interleukin-6 receptor and gp130 expressions and proliferative capability of human CD34+ cells
35. Simultaneous activation of signals through gp130, c-kit, and interleukin-3 receptor promotes a trilineage blood cell production in the absence of terminally acting lineage-specific factors
36. Cytokine receptor expression on hematopoietic stem and progenitor cells
37. Soluble receptors for cytokines and growth factors; generation and biological function
38. Introduction to stem cell biology in vitro. Threshold to the future
39. Optimization of retroviral-mediated gene transfer to human NOD/SCID mouse repopulating cord blood cells through a systematic analysis of protocol variables